Breaking News Instant updates and real-time market news.

AMC

AMC Entertainment

$30.15

-0.45 (-1.47%)

, RGC

Regal Entertainment

$22.11

-0.41 (-1.82%)

04:55
03/22/17
03/22
04:55
03/22/17
04:55

Macquarie to hold a conference

2017 Macquarie Consumer Conference is being held in New York on March 20-22.

AMC

AMC Entertainment

$30.15

-0.45 (-1.47%)

RGC

Regal Entertainment

$22.11

-0.41 (-1.82%)

SFS

Smart & Final Stores

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

  • 28

    Mar

  • 29

    Mar

AMC AMC Entertainment
$30.15

-0.45 (-1.47%)

03/15/17
FBCO
03/15/17
DOWNGRADE
Target $26
FBCO
Underperform
AMC Entertainment downgraded to Underperform from Neutral at Credit Suisse
Credit Suisse analyst Omar Sheikh downgraded AMC Entertainment to Underperform saying 2017 will be a transition year with investments likely depressing cash flow. Over the long term, the analyst believes premium video on demand could be disruptive to the business models of exhibitors. He cut his price target for AMC shares to $26 from $34.
03/07/17
LOOP
03/07/17
NO CHANGE
Target $39
LOOP
Buy
AMC Entertainment has reached compelling entry point, says Loop Capital
Loop Capital analyst David Miller attributes several factors to the recent weakness in AMC Entertainment shares, including the company's secondary offering pushing the stock below its 200-day moving average, selling by certain secondary buyers who only got involved "looking for a pop" off of earnings and concerns about the company's leverage. However, he views the pullback as offering "a rare opportunity" to establish or add to positions at what he considers a trough valuation ahead of a strong Studio slate in 2017 and 2018. Miller has a Buy rating and $39 price target on AMC shares.
03/01/17
MKMP
03/01/17
NO CHANGE
MKMP
AMC Entertainment shares defended at MKM Partners
03/15/17
03/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Express Scripts (ESRX) downgraded to Underperform from Market Perform at Wells Fargo with analyst Peter Costa saying the shares do not reflect the 20%-40% earnings risk related to re-pricing of or losing the Anthem (ANTM) contract. The analyst also sees risk of market share losses related to Express' pharmacy benefit manager model. Costa cut his price target range for the shares to $52-$56 from $79-$85. 2. AMC Entertainment (AMC) downgraded to Underperform from Neutral at Credit Suisse with analyst Omar Sheikh saying 2017 will be a transition year with investments likely depressing cash flow. Over the long term, the analyst believes premium video on demand could be disruptive to the business models of exhibitors. He cut his price target for AMC shares to $26 from $34. 3. American Water (AWK) downgraded to Hold from Buy at HSBC with analyst Verity Mitchell citing the recent rally in the shares and the belief that rising interest rates are likely to be less supportive of a regulated utility that yields only 2.2% for 2017. The analyst keeps a $79 price target for the shares. 4. Citrix (CTXS) downgraded to Neutral on valuation at BofA/Merrill with analyst Kash Rangan citing valuation, and raised his price target to $91 from $87. 5. Ventas (VTR) downgraded to Sell from Neutral at Goldman with analyst Andrew Rosivach saying rising interest rates will meaningfully affect the company's ability to produce external growth. The analyst cut his price target for the shares to $56 from $70. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
RGC Regal Entertainment
$22.11

-0.41 (-1.82%)

02/01/17
02/01/17
DOWNGRADE
Target $20

Underperform
Regal Entertainment downgraded to Underperform at Credit Suisse
As previously reported, Credit Suisse analyst Omar Sheikh downgraded Regal Entertainment (RGC) to Underperform from Neutral saying he sees ticket price and concessions revenue growth continuing to trend lower now that the strength of the 2017/18 movies slates is widely anticipated. The analyst highlights the risk that some studios may explore a change to the exclusive exhibition window, while noting that Regal's largest shareholder may continue to sell. He lowered his price target on the shares to $20 from $22. Sheikh also downgraded AMC Entertainment (AMC) to Neutral.
02/01/17
02/01/17
DOWNGRADE
Target $34

Neutral
IMAX downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Omar Sheikh downgraded IMAX (IMAX) to Neutral from Outperform as he sees balanced risk/reward at current levels, given the strong movie slate in 2017/18, slowing growth in China, the likely 1-2 year period before payback comes through on investments in new initiatives, and the full current multiple that leaves little margin for safety. The analyst lowered his price target on the shares to $34 from $42. Sheikh also downgraded AMC Entertainment (AMC) and Regal Entertainment (RGC).
02/01/17
02/01/17
DOWNGRADE
Target $13

Underperform
National CineMedia downgraded to Underperform at Credit Suisse
As previously reported, Credit Suisse analyst Omar Sheikh downgraded National CineMedia (NCMI) to Underperform from Outperform as he believes 2017 will be a tough year for cinema advertising, which suggests there could be limited scope for the company's inventory utilization and CPMs to grow. The analyst lowered his price target on the shares to $13 from $21. He also downgraded AMC Entertainment (AMC), Regal Entertainment (RGC) and IMAX (IMAX).
02/01/17
02/01/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Buy at Buckingham, to Market Perform from Outperform at FBR Capital, and to Hold from Buy at Evercore ISI. 2. AMC Entertainment (AMC) and IMAX (IMAX) were downgraded to Neutral from Outperform at Credit Suisse, while Regal Entertainment (RGC) was downgraded to Underperform from Neutral. 3. UPS (UPS) downgraded to Market Perform from Outperform at BMO Capital with analyst Fadi Chamoun saying the company's fourth quarter results were "weak," while it lacks positive catalysts in the near-term. 4. Corning (GLW) downgraded to Market Perform from Outperform at Bernstein with analyst Alberto Moel citing valuation. 5. Mobileye (MBLY) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Adam Jonas saying he is positive on ADAS market growth but also sees more rapid commoditization pressuring margins. Jonas expects the pace of growth to be driven by affordability and increased competition, leading to a larger market opportunity, but lower margins and reduced OEM dependency on one dominant technology supplier. Further, the analyst believes Mobileye will need to increase its R&D capacity and internal human resources in order to remain a long-term key player in the industry. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SFS Smart & Final Stores

09/23/16
LEHM
09/23/16
INITIATION
Target $13
LEHM
Equal Weight
Smart & Final Stores initiated with an Equal Weight at Barclays
Barclays analyst Karen Short started Smart & Final Stores with an Equal Weight rating and $13 price target.
10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Wal-Mart 'starting to get its act together' in grocery, says Oppenheimer
After attending Wal-Mart's (WMT) analyst day meeting, Oppenheimer analyst Rupesh Parikh admitted he did not previously look favorably upon the company's strategy to expand into Neighborhood Market and smaller format stores, but he now sees signs that the company is "starting to get its act together in grocery." If Wal-Mart follows through with grocery price investments, it could hurt Kroger (KR), Smart & Final Stores (SFS) and Supervalu (SVU) and be an "indirect negative" for Sprouts Farmers Markets (SFM), Parikh tells investors. However, he also added that he remains confident in the ability of Kroger's management team to at least hold share.
03/06/17
RBCM
03/06/17
NO CHANGE
RBCM
Smart & Final Stores shares should be bought on any weakness,says RBC Capital
RBC Capital analyst William Kirk says that Smart &Final Stores' Q4 results "will remain challenged on comparable store sales and profitability." However, the analyst expects the company to benefit from easing deflation and less tough comps going forward. He recommends buying the shares on any weakness and keeps an Outperform rating. ,
03/14/17
RBCM
03/14/17
NO CHANGE
RBCM
Smart & Final Stores weakness creates buying opportunity, says RBC Capital
RBC Capital analyst William Kirk says that Smart & Final's comp sales will resume growing, partly due to easier comparisons and improving deflation. Kirk thinks that the company's fundamentals remain strong and he believes that the weakness in the stock has created a buying opportunity. He trimmed his price target on the name to $19 from $20 but keeps an Outperform rating.

TODAY'S FREE FLY STORIES

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.90

0.12 (0.20%)

, DAL

Delta Air Lines

$53.27

1 (1.91%)

09:51
10/21/17
10/21
09:51
10/21/17
09:51
Periodicals
Market pounds United, sees American/Delta as possibly safe bets, Barron's says »

United Continental's…

UAL

United Continental

$59.90

0.12 (0.20%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

CZR

Caesars

$12.20

0.15 (1.24%)

09:45
10/21/17
10/21
09:45
10/21/17
09:45
Periodicals
Caesars looks ready to grow again, Barron's says »

After a disastrous 2008…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

DWDP

DowDuPont

$71.18

0.29 (0.41%)

09:40
10/21/17
10/21
09:40
10/21/17
09:40
Periodicals
DowDuPont shares likely to return as much as 30% over next year, Barron's says »

If DowDuPont can cut $3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

0.88 (2.23%)

09:29
10/21/17
10/21
09:29
10/21/17
09:29
Periodicals
Coach shares look undervalued, could rise nearly 30%, Barron's says »

Coach, which has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$96.50

1.8 (1.90%)

, MOH

Molina Healthcare

$64.40

0.76 (1.19%)

09:24
10/21/17
10/21
09:24
10/21/17
09:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$96.50

1.8 (1.90%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

AET

Aetna

$160.84

3.2 (2.03%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

CYH

Community Health

$6.44

0.24 (3.87%)

HCA

HCA Healthcare

$81.05

1.26 (1.58%)

LPNT

LifePoint

$58.35

0.5 (0.86%)

THC

Tenet

$14.66

1.31 (9.81%)

UHS

Universal Health

$112.85

2.31 (2.09%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

FB

Facebook

$174.98

0.42 (0.24%)

INTC

Intel

$40.43

0.34 (0.85%)

IBM

IBM

$162.07

1.17 (0.73%)

MAR

Marriott

$115.02

-0.18 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 29

    Nov

  • 30

    Nov

  • 18

    Mar

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

08:55
10/21/17
10/21
08:55
10/21/17
08:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

08:45
10/21/17
10/21
08:45
10/21/17
08:45
General news
Breaking General news story  »

New York Federal Reserve…

FB

Facebook

$174.98

0.42 (0.24%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

08:25
10/21/17
10/21
08:25
10/21/17
08:25
Periodicals
Regulators inquiries fuel speculation about big tech breakup, Barron's says »

Facebook (FB), Amazon…

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

07:58
10/21/17
10/21
07:58
10/21/17
07:58
Hot Stocks
DBV believes FDA suggested continue moving forward with Viaskin »

DBV Technologies (DBVT)…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

04:55
10/21/17
10/21
04:55
10/21/17
04:55
General news
Breaking General news story  »

New York Federal Reserve…

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

04:55
10/21/17
10/21
04:55
10/21/17
04:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.